HODGKIN DISEASE

This study tests a new treatment for cancers linked to the Epstein-Barr virus (EBV) that have come back or haven't responded to standard care. Doctors are using a bank of pre-made immune cells from healthy donors, which are specially trained to attack EBV-infected cancer cells, a…

This is the first study testing a new experimental drug called PF-08046044/SGN-35C in people with advanced lymphoma that has returned or stopped responding to standard treatments. The trial will enroll 57 adults with specific types of lymphoma to determine the safest dose, unders…

This study is testing a new drug, brentuximab vedotin, added to standard chemotherapy for children with newly diagnosed, advanced Hodgkin lymphoma. The goal is to see if this combination is safe, effective, and what the best dose is for young patients. The trial enrolled about 59…

This study is testing whether adding acupuncture to standard pain care can help patients with multiple myeloma or lymphoma use fewer opioid medications during high-dose chemotherapy. Researchers are comparing two groups: one receiving acupuncture plus usual care, and one receivin…

This study aims to understand and track the long-term health problems that can develop in cancer survivors after their initial treatment is successful. It follows 500 adults who have finished treatment for certain cancers (like breast cancer, lymphoma, and leukemia) and are in re…

This study aims to understand why some families have a higher risk of developing blood and lymph node cancers like leukemia and lymphoma. Researchers are observing and collecting health information from families with a history of these cancers to identify genetic and environmenta…